Trial Profile
Phase IV Clinical Trial of rhGM-CSF Hydro-gel for Topical Application on Deep 2nd Partial Thickness Burn.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs Molgramostim (Primary)
- Indications Burns
- Focus Therapeutic Use
- Sponsors GeneScience Pharmaceuticals
- 05 May 2015 New trial record